http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101902656-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate | 2016-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101902656-B1 |
| titleOfInvention | Anti-cancer and anti-cancer adjuvant composition containing silver nanoparticle |
| abstract | The present invention relates to an anticancer and anticancer adjuvant composition comprising silver nanoparticles as an active ingredient, and more particularly to a silver nanoparticle composition containing silver nanoparticles prepared using a Bacillus clausii microorganism culture supernatant as an active ingredient Anticancer and anticancer adjuvant compositions. The silver nanoparticles prepared by the method of the present invention can control the physical properties of the nanoparticles as well as the organic substances contained in the culture supernatant prevent the aggregation of the nanoparticles and control the pH and the reaction time. In addition, it is involved in the signal transduction of brain glioma factor (BDNF), which plays an important role in cell survival in neuroblastoma, and induces cytotoxicity, and thus has an excellent effect in the treatment of cancer including neuroblastoma. |
| priorityDate | 2016-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 154.